Pilocarpine toxicity and the treatment of xerostomia

Robert Hendrickson, Anthony P. Morocco, Michael I. Greenberg

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Pilocarpine has been used as an ophthalmologic agent for decades; however, toxicity rarely has been reported in the medical literature. Oral pilocarpine tablets, as well as another muscarinic agent (cevimeline), have recently been approved for the treatment of dry mouth (xerostomia). We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome. The patient's symptoms were relieved with 0.5 mg intravenous atropine and she recovered uneventfully. The case is unique in that it is the first reported ingestion of oral pilocarpine tablets and the first dosing error reported for this indication. In addition, this case underscores the importance of communication between physician and patient and the resulting toxicity related to miscommunication.

Original languageEnglish (US)
Pages (from-to)429-432
Number of pages4
JournalJournal of Emergency Medicine
Volume26
Issue number4
DOIs
StatePublished - May 2004

Fingerprint

Xerostomia
Pilocarpine
Tablets
Cholinergic Agents
Sjogren's Syndrome
Therapeutics
Bradycardia
Atropine
Hypotension
Mouth
Eating
Communication
Physicians

Keywords

  • Medical mistakes
  • Overdose
  • Pilocarpine
  • Toxicity
  • Toxicology

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Pilocarpine toxicity and the treatment of xerostomia. / Hendrickson, Robert; Morocco, Anthony P.; Greenberg, Michael I.

In: Journal of Emergency Medicine, Vol. 26, No. 4, 05.2004, p. 429-432.

Research output: Contribution to journalArticle

Hendrickson, Robert ; Morocco, Anthony P. ; Greenberg, Michael I. / Pilocarpine toxicity and the treatment of xerostomia. In: Journal of Emergency Medicine. 2004 ; Vol. 26, No. 4. pp. 429-432.
@article{40197ef46da14810bc9a304aa925fb3c,
title = "Pilocarpine toxicity and the treatment of xerostomia",
abstract = "Pilocarpine has been used as an ophthalmologic agent for decades; however, toxicity rarely has been reported in the medical literature. Oral pilocarpine tablets, as well as another muscarinic agent (cevimeline), have recently been approved for the treatment of dry mouth (xerostomia). We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome. The patient's symptoms were relieved with 0.5 mg intravenous atropine and she recovered uneventfully. The case is unique in that it is the first reported ingestion of oral pilocarpine tablets and the first dosing error reported for this indication. In addition, this case underscores the importance of communication between physician and patient and the resulting toxicity related to miscommunication.",
keywords = "Medical mistakes, Overdose, Pilocarpine, Toxicity, Toxicology",
author = "Robert Hendrickson and Morocco, {Anthony P.} and Greenberg, {Michael I.}",
year = "2004",
month = "5",
doi = "10.1016/j.jemermed.2003.09.013",
language = "English (US)",
volume = "26",
pages = "429--432",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Pilocarpine toxicity and the treatment of xerostomia

AU - Hendrickson, Robert

AU - Morocco, Anthony P.

AU - Greenberg, Michael I.

PY - 2004/5

Y1 - 2004/5

N2 - Pilocarpine has been used as an ophthalmologic agent for decades; however, toxicity rarely has been reported in the medical literature. Oral pilocarpine tablets, as well as another muscarinic agent (cevimeline), have recently been approved for the treatment of dry mouth (xerostomia). We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome. The patient's symptoms were relieved with 0.5 mg intravenous atropine and she recovered uneventfully. The case is unique in that it is the first reported ingestion of oral pilocarpine tablets and the first dosing error reported for this indication. In addition, this case underscores the importance of communication between physician and patient and the resulting toxicity related to miscommunication.

AB - Pilocarpine has been used as an ophthalmologic agent for decades; however, toxicity rarely has been reported in the medical literature. Oral pilocarpine tablets, as well as another muscarinic agent (cevimeline), have recently been approved for the treatment of dry mouth (xerostomia). We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome. The patient's symptoms were relieved with 0.5 mg intravenous atropine and she recovered uneventfully. The case is unique in that it is the first reported ingestion of oral pilocarpine tablets and the first dosing error reported for this indication. In addition, this case underscores the importance of communication between physician and patient and the resulting toxicity related to miscommunication.

KW - Medical mistakes

KW - Overdose

KW - Pilocarpine

KW - Toxicity

KW - Toxicology

UR - http://www.scopus.com/inward/record.url?scp=1942452258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942452258&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2003.09.013

DO - 10.1016/j.jemermed.2003.09.013

M3 - Article

VL - 26

SP - 429

EP - 432

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 4

ER -